Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Sharon A. Sutherland, MD joined Cleveland Clinic in 2003, and in 2011 was appointed the Quality Improvement Officer for Obstetrics/Gynecology and Women's Health Institute at Cleveland Clinic. In her current role, she supports patient safety and quality improvement activities in all affiliated sites of Women's Health Institute.
Dr. Sutherland is certified by the American Board of Obstetrics and Gynecology. Dr. Sutherland has a special interest in minimally invasive gynecology procedures, including hysteroscopy, endometrial ablation, laparoscopy and laparoscopic and hysteroscopic sterilization procedures. She mentors ob/gyn residents, and she is a Clinical Assistant Professor at Case Western Reserve University Cleveland Clinic Lerner College of Medicine.
Quality Improvement Officer, Ob/Gyn and Women's Health Institute
National Quality Forum (NQF) Perinatal and Reproductive Healthcare Steering Committee, 2011
Ob/Gyn Workgroup for ICD-10-CM/PCS conversion of Agency for Healthcare Research and Quality (AHRQ) Quality Indicator, 2012
Standing multi-specialty work group to review the Agency for Healthcare Research and Quality (AHRQ) Quality Indicators, 2013
Clinical Advisory Group, Perinatal Episode, Ohio Governor's Office of Health Transformation, 2013
general gynecology, abnormal uterine bleeding, contraception, hysteroscopic sterilization, ovarian cysts, colposcopy and LEEP procedures, hysterectomy, oophorectomy, endometrial ablation, laparoscopy
Awards & Honors
World Class Service Award, OB/GYN, Cleveland Clinic, 2007
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/6/2013, Dr. Sutherland has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.